Skip to main content
SpringerLink
Log in
Book cover

Rehabilitation in Orthopädie und Unfallchirurgie pp 246–257Cite as

Osteoporose: Diagnostik — Prävention — Therapie

  • Chapter

  • 2304 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anderson GL et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291: 1701–1712

    PubMed  Google Scholar 

  • Black DM et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348: 1535–1541

    PubMed  Google Scholar 

  • Black DM et al. (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207–15

    PubMed  Google Scholar 

  • Chapuy MC et al. (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327: 1637–1642

    PubMed  Google Scholar 

  • Chapuy MC et al. (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308: 1081–1082

    PubMed  Google Scholar 

  • Chesnut III CH et al. (2000) A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 109: 267–276

    PubMed  Google Scholar 

  • Chevalley T et al. (1994) Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-Dreplete elderly patients. Osteoporos Int 4: 245–256

    PubMed  Google Scholar 

  • Cranney A et al. (2002) Summary of meta-analyses of therapies for postmenopausal osteoprosis. Endocrine Rev 23(4): 570–578

    Google Scholar 

  • Delmas PD (1999) How should the risk of postmenopausal women be assessed? Osteoporos Int 9(Suppl 2): S33–S39

    Google Scholar 

  • Eddy DM et al. (1998) Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 8: 31–37

    Google Scholar 

  • Ekman M et al. (1991) Comparative absorption of calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet, and chloride solution. Bone 12(2): 93–97

    PubMed  Google Scholar 

  • Ettinger B et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282: 637–645

    PubMed  Google Scholar 

  • Finkelstein JS et al. (2003) The effects of parathyroid hormone, alendronate or both in men with osteoporosis. N Engl J Med 349:1216–1226

    PubMed  Google Scholar 

  • Hauer D et al. (2000) Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporos Int 11: 727–738

    PubMed  Google Scholar 

  • Hosking D et al. (2002) Once weekly alendronate produces a greater decrease in bone resorption than does daily risedronate. American Society for Bone and Mineral Research 24th Annual Meeting, San Antonio, Texas, Sept. 2002

    Google Scholar 

  • Kannus P et al. (2000) Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343: 1506–1513

    PubMed  Google Scholar 

  • Lauritzen JB et al. (1993) Effect of external hip protectors on hip fractures. Lancet 341: 3–11

    Google Scholar 

  • Lips P et al. (1996) Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 124: 400–406

    PubMed  Google Scholar 

  • Lufkin EG et al. (1992) Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117: 1–9

    PubMed  Google Scholar 

  • Marcus R (1993) Cyclic etidonate: has the rose lost its bloom? Am J Med 95: 555–556

    PubMed  Google Scholar 

  • Marcus R et al. (2002) Antiresorptive treatment of postmenopausal osteoporosis: Comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocrine Rev 23(1): 16–37

    Google Scholar 

  • Marshall D et al. (1996) Meta-analysis of how well measures of bone mineral density predict ocurrence of osteoporotic fractures. BMJ 312: 1254–1259

    PubMed  Google Scholar 

  • McClung M et al. (2001) Risedronate reduces hip fracturesin elderly postmenopausal women. N Engl J Med 344: 333–340

    PubMed  Google Scholar 

  • Meunier PJ et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350: 459–68

    PubMed  Google Scholar 

  • Neer RM et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344: 1434–1441

    PubMed  Google Scholar 

  • Orwoll E et al. (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610

    PubMed  Google Scholar 

  • Pfeifer M et al. (2000) Effects of a short-term vitamin D and calcium supplementation an body sway and secondary hyperparathyroidism in elderly women. J Bone Mineral Res 15: 1113–1118

    Google Scholar 

  • Pfeifer M et al. (2004) Effects of a new spinal orthosis on posture, trunk strength and quality of life in women with postmenopausal osteoporosis — A randomised trial. Am J Phys Med Rehabil 83: 177–186

    PubMed  Google Scholar 

  • Recker RR et al. (1995) Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 9: 1961–1966

    Google Scholar 

  • Reginster J et al. (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11: 83–91

    PubMed  Google Scholar 

  • Reginster JY et al. (1993) Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporos Int 3(5): 271–275

    PubMed  Google Scholar 

  • Reginster JY et al. (2001) Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion. Gynecol Endocrinol 15: 56–62

    PubMed  Google Scholar 

  • Ringe JD et al. (2001) Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab 86(11): 5252–5255

    PubMed  Google Scholar 

  • Ross PD et al. (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114: 919–923

    PubMed  Google Scholar 

  • Roussouw JE (2002) for the WHI Investigators Writing Group. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321–333

    PubMed  Google Scholar 

  • Saag K (1998) Alendronate for the treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339: 292–299

    PubMed  Google Scholar 

  • Sinaki M et al. (2002) Stronger back muscles reduce the incidence of vertebral fractures: A prospective 10 year follow-up of postmenopausal women. Bone 30: 836–841

    PubMed  Google Scholar 

  • Tinetti ME (2003) Preventing falls in elderly people. N Engl J Med 348: 42–49

    PubMed  Google Scholar 

  • Trivedi DP et al. (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: a randomized, doubleblind controlled trial. BMJ 326: 469–475

    PubMed  Google Scholar 

  • Wasnich RD, Miller PD (2000) Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 85: 231–236

    PubMed  Google Scholar 

  • WHI — The Women’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19: 61–109

    Google Scholar 

Download references

Authors
  1. A. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Friebe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinischer Dienst der Krankenversicherung Sachsen-Anhalt, Breiter Weg 19c, 39104, Magdeburg

    Volkmar Stein

  2. Klinik Münsterland der LVA Westfalen Klinik für Orthopädie, Auf der Stöwwe 11, 49214, Bad Rothenfelde

    Bernhard Greitemann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Peters, A., Friebe, H. (2005). Osteoporose: Diagnostik — Prävention — Therapie. In: Stein, V., Greitemann, B. (eds) Rehabilitation in Orthopädie und Unfallchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26634-8_29

Download citation

  • DOI: https://doi.org/10.1007/3-540-26634-8_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20008-6

  • Online ISBN: 978-3-540-26634-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation